Clinical profile and prognostic significance of intradialytic hypoxemia in patients undergoing hemodialysis

Keywords: chronic kidney disease, renal replacement therapy, hemodialysis, survival, intradialytic hypoxemia, intradialytic arterial hypertension.

Abstract

Intradialytic hypoxemia (IH) is a frequently observed but insufficiently characterized phenomenon in maintenance hemodialysis (HD). Its associations with clinical phenotype, nutritional-inflammatory markers, and short-term outcomes in routine HD practice remain inadequately defined. The present study aimed to characterize the clinical profile of patients with IH and determine its prognostic significance for hospitalization rates and one-year survival.

Methods. A prospective single-center study included 120 HD patients. IH was defined as mean SpO₂ <94%, SpO₂ <94% for ≥10% of the HD session, and/or PaO₂ <70 mmHg. Patients were stratified into IH (n=26) and non-IH groups (n=94). Arterial blood gases, SpO₂ trends, spirometry, biochemical parameters, hospitalization frequency, and survival were evaluated.

Results. Patients with IH demonstrated a lower PaO₂: 68.1±5.4 vs. 87.3±7.2 mmHg (p<0.0001); lower mean SpO₂: 92.1±1.8% vs. 96.4±1.2% (p<0.001); greater duration of desaturation (SpO₂ <94%): 62.6% vs. 5.1% of session time (p<0.0001); and lower serum albumin: 34.2±4.8 vs. 38.5±3.9 g/L (p<0.001). Concomitant intradialytic hypertension was more frequent in the IH group (34.6% vs. 11.8%, p=0.0078). Hospitalization frequency was markedly higher among patients with IH: 1.7–2.1 hospitalizations per patient per year, depending on the presence of intradialytic hypertension, compared with 1.2–1.6 in the non-IH group (U=2359.0; p=2.01×10⁻¹⁹). A trend toward reduced one-year survival was observed in the IH group: 81.62% vs. 91.49% (log-rank p=0.06).

Conclusions. IH in HD patients is associated with significant impairments in oxygenation, lower nutritional–inflammatory status, and substantially higher hospitalization rates, with a trend toward reduced survival. IH may represent a clinically relevant marker of elevated short-term risk. Routine SpO₂ monitoring may improve early identification of high-risk patients.

 

Downloads

Download data is not yet available.

References

KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of CKD. Kidney Int Suppl. [Internet]. 2013;3(1):1–163. Available from: https://kdigo.org/wp-content/uploads/2017/02/KDIGO_2012_CKD_GL.pdf.

World Health Organization. Pulse oximetry training manual Geneva: WHO Press. [Internet]. 2011; 24. (WHO Patient Safety). Available from: https://cdn.who.int/media/docs/default-source/patient-safety/pulse-oximetry/who-ps-pulse-oxymetry-training-manual-en.pdf?sfvrsn=322cb7ae_6.

Kooman JP, Stenvinkel P, Shiels PG, Feelisch M, Canaud B, Kotanko P. The oxygen cascade in patients treated with hemodialysis and native high-altitude dwellers: lessons from extreme physiology to benefit patients with end-stage renal disease. Am J Physiol Renal Physiol. 2021;320(3):249–61. doi: 10.1152/ajprenal.00540.2020.

McGuire S, Krishnan N, Malik AR, Waddell A, Russell SL, Denton F, et al. Hypoxia during maintenance hemodialysis—the critical role of pH. Clin Kidney J. 2023;16(2):262-71. doi: 10.1093/ckj/sfac191.

Bhutta BS, Alghoula F, Berim I. Hypoxia [Internet]. Treasure Island (FL): StatPearls Publishing. [Internet]. 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482316/.

Prasad B, Hemmet J, Suri R. Five things to know about intradialytic hypertension. Can J Kidney Health Dis. 2022;9:1–3. doi: 10.1177/20543581221106657.

Hartzell S, Haverly M, Farouk S, Kuntsevich V, Cantarelli C, Cravedi P. Prolonged intradialytic hypoxemia is associated with functional disturbances in erythrocytes. Kidney Int Rep. 2021;6(10):2702–2705. doi: 10.1016/j.ekir.2021.07.005.

Cohen-Hagai K, Nacasch N, Sternschuss A, Ohana M, Wolach B, Benchetrit S, et al. Malnutrition and inflammation in hemodialysis patients: comparative evaluation of neutrophil reactive oxygen formation. Nutrition. 2020;78:110793. doi: 10.1016/j.nut.2020.110793.

Rotondi S, Tartaglione L, Muci ML, Pasquali M, Panocchia N, Aucella F, et al. Oxygen extraction and mortality in patients undergoing chronic haemodialysis treatment: a multicentre study. J Clin Med. 2022;12(1):138. doi: 10.3390/jcm12010138.

Meyring-Wösten A, Zhang H, Ye X, Fuertinger DH, Chan L, Kappel F, et al. Intradialytic Hypoxemia and Clinical Outcomes in Patients on Hemodialysis. Clin J Am Soc Nephrol. 2016;11(4):616-25. doi: 10.2215/CJN.08510815.

Chan L, Zhang H, Meyring-Wösten A, Campos I, Fuertinger D, Thijssen S, et al. Intradialytic Central Venous Oxygen Saturation is Associated with Clinical Outcomes in Hemodialysis Patients. Sci Rep. 2017;7(1):8581. doi: 10.1038/s41598-017-09233-x.

Zhang H, Campos I, Chan L, Meyring-Wösten A, Tapia Silva LM, Rivera Fuentes L, et al. Association of Central Venous Oxygen Saturation Variability and Mortality in Hemodialysis Patients. Blood Purif. 2019;47(1-3):246-253. doi: 10.1159/000494630.

Campos I, Chan L, Zhang H, Deziel S, Vaughn C, Meyring-Wösten A, et al. Intradialytic hypoxemia in chronic hemodialysis patients. Blood Purif. 2016;41(1-3):177–87. doi: 10.1159/000441271.

Dias GF, Bonan NB, Steiner TM, Tozoni SS, Rodrigues S, Nakao LS, et al. Indoxyl sulfate, a uremic toxin, stimulates reactive oxygen species production and erythrocyte cell death supposedly by an organic anion transporter 2 (OAT2) and NADPH oxidase activity-dependent pathways. Toxins (Basel). 2018;10(7):280. doi:10.3390/toxins10070280.

Sahathevan S, Khor BH, Ng HM, Abdul Gafor AH, Mat Daud ZA, Mafra D, et al. Understanding development of malnutrition in hemodialysis patients: a narrative review. Nutrients. 2020;12(10):3147. doi: 10.3390/nu12103147.

Mokhtar SA, Ahmed LI, Hadad SM. Correlations between intradialytic hypoxemia and complications in patients undergoing regular hemodialysis. Al-Azhar Int Med J. 2023;4(12):Article 24. doi: 10.58675/2682-339X.2153.

Iatridi F, Theodorakopoulou MP, Karagiannidis AG, Sarafidis P. Intradialytic hypertension in maintenance hemodialysis. Curr Hypertens Rep. 2024;27(1):1. doi:10.1007/s11906-024-01320-5.

Buchanan C, Mohammed A, Cox E, Kohler K, Canaud B, Taal MW, et al. Intradialytic cardiac magnetic resonance imaging to assess cardiovascular responses in a short-term trial of hemodiafiltration and hemodialysis. J Am Soc Nephrol. 2016;28(5):1269-77. doi: 10.1681/ASN.2016060686.


Abstract views: 223
PDF Downloads: 172
Published
2025-12-08
How to Cite
Kushnirenko, S., & Lysianska, O. (2025). Clinical profile and prognostic significance of intradialytic hypoxemia in patients undergoing hemodialysis. Ukrainian Journal of Nephrology and Dialysis, (4(88), 55-62. https://doi.org/10.31450/ukrjnd.4(88).2025.07